Lia DeGroot

The block­buster type 2 di­a­betes and obe­si­ty drug semaglu­tide was as­so­ci­at­ed with a low­er risk of sui­ci­dal ideation com­pared to oth­er obe­si­ty and type 2

Re­pub­li­can House law­mak­ers on the En­er­gy & Com­merce com­mit­tee are ask­ing the FDA to hand over doc­u­ments re­lat­ing to in­ter­nal sci­en­tif­ic dis­agree­ments at the agency,

Pres­i­dent Joe Biden is di­rect­ing HHS to use the De­fense Pro­duc­tion Act to boost the pro­duc­tion of drugs in short­age, he wrote in a memo

Long­board Phar­ma­ceu­ti­cals’ stock $LBPH sky­rock­et­ed by more than 200% Tues­day af­ter the com­pa­ny re­leased topline da­ta from its study for an oral drug to treat

The FDA is warn­ing con­sumers not to use coun­ter­feit Ozem­pic af­ter it found thou­sands of units of fake prod­uct in the sup­ply chain. The agency

The Con­gres­sion­al Bud­get Of­fice ex­pects that drug­mak­ers will raise their prices and of­fer larg­er re­bates for new drugs be­cause of pro­vi­sions in the In­fla­tion Re­duc­tion

A Sep­tem­ber in­spec­tion of Mod­er­na’s man­u­fac­tur­ing plant in Nor­wood, MA, found laps­es in clean­ing pro­ce­dures and ex­pired prod­uct, ac­cord­ing to an agency re­port ob­tained by

The FDA is work­ing to es­tab­lish a new of­fice — dubbed the Of­fice of the Chief Med­ical Of­fi­cer — to co­or­di­nate cross-agency op­er­a­tions amid the

The FDA is en­cour­ag­ing de­vel­op­ers of Covid-19 mon­o­clon­al an­ti­bod­ies to col­lab­o­rate and bet­ter tar­get emerg­ing vari­ants in fi­nal guid­ance pub­lished on Wednes­day. The reg­u­la­tor ex­plained

The FDA on Tues­day grant­ed Mer­ck pri­or­i­ty re­view for its in­ves­ti­ga­tion­al pneu­mo­coc­cal vac­cine, mak­ing strides ahead of Pfiz­er in the com­pa­nies’ years­long con­test atop the